Christine Esposito, Managing Editor01.22.21
Amyris, Inc. is expanding its portfolio of consumer brands by launching a new range of Terasana branded clean beauty products focused on sustainably sourced natural cannabinoids.
With Terasana, Amyris says it is focused on offering leading skincare applications formulated with unique natural cannabinoids that deliver high efficacy sustainable products direct to consumers.
Through its proprietary lab-to-market synthetic biology platform, Amyris recently commercialized a clean, sustainable, fermentation based CBG (cannabigerol), a non-psychoactive cannabinoid.
Early results from clinical studies demonstrate that Amyris CBG skincare applications formulated with natural sugarcane based Neossance squalane provide significantly better therapeutic effect and efficacy compared to many standard CBD (cannabidiol) topical applications, addressing conditions like dry skin, skin flaking, irritation, redness and blemishes.
"We are very pleased with the early clinical results demonstrating Amyris CBG benefits including enhanced performance when combined with squalane. We are excited to lead the cannabinoid industry with science-backed, sustainably and cost-effectively sourced minor cannabinoids delivering outstanding performance for consumers and our planet," said John Melo, president and CEO of Amyris. "During the fourth quarter of 2020 we sold out our entire first industrial production of clean CBG as an ingredient for use in flavors and fragrances. We are very optimistic about the future of clean cannabinoids and the efficacy they can bring to skincare as a logical extension to our existing consumer portfolio. Amyris's consumer business is nearly half of total product revenue and represents the fastest growing business activity in our portfolio."
Terasana is a trademark of Manhattan Avenue Brands Group in Manhattan Beach, CA.
Kalichem
With Terasana, Amyris says it is focused on offering leading skincare applications formulated with unique natural cannabinoids that deliver high efficacy sustainable products direct to consumers.
Through its proprietary lab-to-market synthetic biology platform, Amyris recently commercialized a clean, sustainable, fermentation based CBG (cannabigerol), a non-psychoactive cannabinoid.
Early results from clinical studies demonstrate that Amyris CBG skincare applications formulated with natural sugarcane based Neossance squalane provide significantly better therapeutic effect and efficacy compared to many standard CBD (cannabidiol) topical applications, addressing conditions like dry skin, skin flaking, irritation, redness and blemishes.
"We are very pleased with the early clinical results demonstrating Amyris CBG benefits including enhanced performance when combined with squalane. We are excited to lead the cannabinoid industry with science-backed, sustainably and cost-effectively sourced minor cannabinoids delivering outstanding performance for consumers and our planet," said John Melo, president and CEO of Amyris. "During the fourth quarter of 2020 we sold out our entire first industrial production of clean CBG as an ingredient for use in flavors and fragrances. We are very optimistic about the future of clean cannabinoids and the efficacy they can bring to skincare as a logical extension to our existing consumer portfolio. Amyris's consumer business is nearly half of total product revenue and represents the fastest growing business activity in our portfolio."
Terasana is a trademark of Manhattan Avenue Brands Group in Manhattan Beach, CA.
Kalichem